Literature DB >> 23053804

Investigating the feasibility of using a grit blasting process to coat nitinol stents with hydroxyapatite.

F Keady1, B P Murphy.   

Abstract

This study investigates the feasibility of utilising a grit blasting process to coat three nitinol substrates (a planer 2D surface, a circular wire and a cardiovascular stent geometry) with a hydroxyapatite coating. Surface characteristics of the coating on the three substrates were determined and additionally the durability of the coating post fatigue testing was analysed. The coating process resulted in a consistent covering of the substrate that resulted in an extremely hydrophilic stent surface. The surface roughness was dependant on grit blasting particle size. A general trend of smaller particle size resulted in a lower surface roughness, while particle size did not have an effect on the hydroxyapatite coating thickness. Fatigue integrity tests that simulated 16 months implantation demonstrated minimal damage to the coating. In conclusion we demonstrated the initial feasibility of using a grit blasting method to produce a consistent, hydrophilic, and durable HAp stent coating that has the capability of incorporating a drug eluting function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053804     DOI: 10.1007/s10856-012-4775-3

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  15 in total

1.  Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries.

Authors:  D S Baim; D E Cutlip; C D O'Shaughnessy; J B Hermiller; D J Kereiakes; A Giambartolomei; S Katz; A J Lansky; M Fitzpatrick; J J Popma; K K Ho; M B Leon; R E Kuntz
Journal:  Am J Cardiol       Date:  2001-01-15       Impact factor: 2.778

Review 2.  Critical overview of Nitinol surfaces and their modifications for medical applications.

Authors:  S Shabalovskaya; J Anderegg; J Van Humbeeck
Journal:  Acta Biomater       Date:  2008-02-06       Impact factor: 8.947

3.  In vitro and in vivo bioactivity of CoBlast hydroxyapatite coating and the effect of impaction on its osteoconductivity.

Authors:  Fei Tan; Mariam Naciri; Denis Dowling; Mohamed Al-Rubeai
Journal:  Biotechnol Adv       Date:  2011-07-23       Impact factor: 14.227

4.  A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial.

Authors:  Gregg W Stone; Paul S Teirstein; Ian T Meredith; Bruno Farah; Christophe L Dubois; Robert L Feldman; Joseph Dens; Nobuhisa Hagiwara; Dominic J Allocco; Keith D Dawkins
Journal:  J Am Coll Cardiol       Date:  2011-04-04       Impact factor: 24.094

5.  Growth and phenotypic expression of human endothelial cells cultured on a glass-reinforced hydroxyapatite.

Authors:  J M Silva Marques; P S Gomes; M A Silva; A M Silvério Cabrita; J D Santos; M H Fernandes
Journal:  J Mater Sci Mater Med       Date:  2008-11-06       Impact factor: 3.896

6.  First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial.

Authors:  Ian T Meredith; John Ormiston; Robert Whitbourn; I Patrick Kay; David Muller; Raoul Bonan; Jeffrey J Popma; Donald E Cutlip; Peter Fitzgerald; Ross Prpic; Richard E Kuntz
Journal:  EuroIntervention       Date:  2005-08       Impact factor: 6.534

7.  Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study.

Authors:  Marc Bosiers; Giovanni Torsello; Hans-Martin Gissler; Johannes Ruef; Stefan Müller-Hülsbeck; Thomas Jahnke; Patrick Peeters; Kim Daenens; Johannes Lammer; Herman Schroë; Klaus Mathias; Renate Koppensteiner; Frank Vermassen; Dierk Scheinert
Journal:  J Endovasc Ther       Date:  2009-06       Impact factor: 3.487

8.  TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.

Authors:  Eberhard Grube; Sigmund Silber; Karl Eugen Hauptmann; Ralf Mueller; Lutz Buellesfeld; Ulrich Gerckens; Mary E Russell
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

9.  Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing.

Authors:  Wim J van der Giessen; Oana Sorop; Patrick W Serruys; Ilona Peters-Krabbendam; Heleen M M van Beusekom
Journal:  JACC Cardiovasc Interv       Date:  2009-04       Impact factor: 11.195

Review 10.  Vascular pathology of drug-eluting stents.

Authors:  Gaku Nakazawa; Aloke V Finn; Renu Virmani
Journal:  Herz       Date:  2007-06       Impact factor: 1.443

View more
  2 in total

Review 1.  Hydroxylapatite nanoparticles: fabrication methods and medical applications.

Authors:  Masahiro Okada; Tsutomu Furuzono
Journal:  Sci Technol Adv Mater       Date:  2012-12-28       Impact factor: 8.090

2.  Biocompatibility of new materials based on nano-structured nitinol with titanium and tantalum composite surface layers: experimental analysis in vitro and in vivo.

Authors:  Mikhail A Sevost'yanov; Elena O Nasakina; Alexander S Baikin; Konstantin V Sergienko; Sergey V Konushkin; Mikhail A Kaplan; Alexey V Seregin; Alexander V Leonov; Valery A Kozlov; Alexey V Shkirin; Nikolai F Bunkin; Alexey G Kolmakov; Sergey V Simakov; Sergey V Gudkov
Journal:  J Mater Sci Mater Med       Date:  2018-03-15       Impact factor: 3.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.